167 related articles for article (PubMed ID: 30958388)
1. Brief Report: Hazardous Cannabis Use and Monocyte Activation Among Methamphetamine Users With Treated HIV Infection.
Vidot DC; Manuzak JA; Klatt NR; Pallikkuth S; Roach M; Dilworth SE; Pahwa S; Carrico AW
J Acquir Immune Defic Syndr; 2019 Jul; 81(3):361-364. PubMed ID: 30958388
[TBL] [Abstract][Full Text] [Related]
2. Substance-associated elevations in monocyte activation among methamphetamine users with treated HIV infection.
Carrico AW; Cherenack EM; Roach ME; Riley ED; Oni O; Dilworth SE; Shoptaw S; Hunt P; Roy S; Pallikkuth S; Pahwa S
AIDS; 2018 Mar; 32(6):767-771. PubMed ID: 29369159
[TBL] [Abstract][Full Text] [Related]
3. Psychosocial Correlates of Monocyte Activation and HIV Persistence in Methamphetamine Users.
Grosgebauer K; Salinas J; Sharkey M; Roach M; Pallikkuth S; Dilworth SE; Pahwa S; Koru-Sengul T; Stevenson M; Carrico AW
J Neuroimmune Pharmacol; 2019 Mar; 14(1):16-22. PubMed ID: 30046962
[TBL] [Abstract][Full Text] [Related]
4. Stimulant Use and Viral Suppression in the Era of Universal Antiretroviral Therapy.
Carrico AW; Hunt PW; Neilands TB; Dilworth SE; Martin JN; Deeks SG; Riley ED
J Acquir Immune Defic Syndr; 2019 Jan; 80(1):89-93. PubMed ID: 30272634
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial of a positive affect intervention to reduce HIV viral load among sexual minority men who use methamphetamine.
Carrico AW; Neilands TB; Dilworth SE; Evans JL; Gόmez W; Jain JP; Gandhi M; Shoptaw S; Horvath KJ; Coffin L; Discepola MV; Andrews R; Woods WJ; Feaster DJ; Moskowitz JT
J Int AIDS Soc; 2019 Dec; 22(12):e25436. PubMed ID: 31860172
[TBL] [Abstract][Full Text] [Related]
6. Heavy Cannabis Use Associated With Reduction in Activated and Inflammatory Immune Cell Frequencies in Antiretroviral Therapy-Treated Human Immunodeficiency Virus-Infected Individuals.
Manuzak JA; Gott TM; Kirkwood JS; Coronado E; Hensley-McBain T; Miller C; Cheu RK; Collier AC; Funderburg NT; Martin JN; Wu MC; Isoherranen N; Hunt PW; Klatt NR
Clin Infect Dis; 2018 Jun; 66(12):1872-1882. PubMed ID: 29471387
[TBL] [Abstract][Full Text] [Related]
7. Over the influence: The HIV care continuum among methamphetamine-using men who have sex with men.
Jin H; Ogunbajo A; Mimiaga MJ; Duncan DT; Boyer E; Chai P; Dilworth SE; Carrico AW
Drug Alcohol Depend; 2018 Nov; 192():125-128. PubMed ID: 30248558
[TBL] [Abstract][Full Text] [Related]
8. Distinct inflammatory profiles in HIV-infected individuals under antiretroviral therapy using cannabis, cocaine or cannabis plus cocaine.
Castro FOF; Silva JM; Dorneles GP; Barros JBS; Ribeiro CB; Noronha I; Barbosa GR; Souza LCS; Guilarde AO; Pereira AJCS; Guimarães RF; Oliveira TF; Oliveira SEF; Peres A; Romão PRT; Pfrimer IAH; Fonseca SGD
AIDS; 2019 Oct; 33(12):1831-1842. PubMed ID: 31490211
[TBL] [Abstract][Full Text] [Related]
9. The impact of comorbid cannabis and methamphetamine use on mental health among regular ecstasy users.
Scott LA; Roxburgh A; Bruno R; Matthews A; Burns L
Addict Behav; 2012 Sep; 37(9):1058-62. PubMed ID: 22607716
[TBL] [Abstract][Full Text] [Related]
10. Cannabis use is associated with monocyte activation (sCD163) in patients admitted for alcohol use disorder treatment.
Fuster D; García-Calvo X; Bolao F; Zuluaga P; Rocamora G; Hernández-Rubio A; Sanvisens A; Tor J; Muga R
Drug Alcohol Depend; 2020 Nov; 216():108231. PubMed ID: 32818911
[TBL] [Abstract][Full Text] [Related]
11. Blue Monday: Co-occurring Stimulant Use and HIV Persistence Predict Dysregulated Catecholamine Synthesis.
Chahine A; Koru-Sengul T; Feaster DJ; Dilworth SE; Antoni MH; Klatt N; Roach ME; Pallikkuth S; Sharkey M; Salinas J; Stevenson M; Pahwa S; Fuchs D; Carrico AW
J Acquir Immune Defic Syndr; 2021 Mar; 86(3):353-360. PubMed ID: 33165125
[TBL] [Abstract][Full Text] [Related]
12. Tobacco, alcohol, cannabis, and illicit drug use and their association with CD4/CD8 cell count ratio in people with controlled HIV: a cross-sectional study (ANRS CO3 AQUIVIH-NA-QuAliV).
Devos S; Bonnet F; Hessamfar M; Neau D; Vareil MO; Leleux O; Cazanave C; Rouanes N; Duffau P; Lazaro E; Dabis F; Wittkop L; Barger D;
BMC Infect Dis; 2023 Jan; 23(1):16. PubMed ID: 36624391
[TBL] [Abstract][Full Text] [Related]
13. Amphetamine use and its associations with antiretroviral adherence and viral load among sexual minority men and transgender women living with HIV.
Brousseau NM; Kalichman SC; Watson RJ; Eaton LA
AIDS Care; 2023 Oct; 35(10):1472-1479. PubMed ID: 37139536
[TBL] [Abstract][Full Text] [Related]
14. Getting to the point: Methamphetamine injection is associated with biomarkers relevant to HIV pathogenesis.
Miller M; Lee JY; Fulcher JA; Roach ME; Dilworth SE; Chahine A; Pallikkuth S; Fuchs D; Pahwa S; Carrico AW
Drug Alcohol Depend; 2020 Aug; 213():108133. PubMed ID: 32580112
[TBL] [Abstract][Full Text] [Related]
15. Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men.
Parsons JT; Kowalczyk WJ; Botsko M; Tomassilli J; Golub SA
AIDS Behav; 2013 May; 17(4):1478-87. PubMed ID: 23553345
[TBL] [Abstract][Full Text] [Related]
16. Sexual Minority Stress and Cellular Aging in Methamphetamine-Using Sexual Minority Men With Treated HIV.
Ghanooni D; Carrico AW; Williams R; Glynn TR; Moskowitz JT; Pahwa S; Pallikkuth S; Roach ME; Dilworth S; Aouizerat BE; Flentje A
Psychosom Med; 2022 Oct; 84(8):949-956. PubMed ID: 35980781
[TBL] [Abstract][Full Text] [Related]
17. Methamphetamine Use Associated with Non-adherence to Antiretroviral Treatment in Men Who Have Sex with Men.
Lai HH; Kuo YC; Kuo CJ; Lai YJ; Chen M; Chen YT; Chen CC; Yen MY; Hu BS; Wang TH; Wang CC; Kuo LL; Yen TF; Chuang PH; Yen YF
Sci Rep; 2020 Apr; 10(1):7131. PubMed ID: 32346081
[TBL] [Abstract][Full Text] [Related]
18. Comparative impact of methamphetamine and other drug use on viral suppression among sexual minority men on antiretroviral therapy.
Fulcher JA; Javanbakht M; Shover CL; Ragsdale A; Brookmeyer R; Shoptaw S; Gorbach PM
Drug Alcohol Depend; 2021 Apr; 221():108622. PubMed ID: 33631545
[TBL] [Abstract][Full Text] [Related]
19. Recent stimulant use and leukocyte gene expression in methamphetamine users with treated HIV infection.
Carrico AW; Flentje A; Kober K; Lee S; Hunt P; Riley ED; Shoptaw S; Flowers E; Dilworth SE; Pahwa S; Aouizerat BE
Brain Behav Immun; 2018 Jul; 71():108-115. PubMed ID: 29679637
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
Lee J; Lee JY; Meade CS; Cohn M; Chahine A; Dilworth SE; Magidson JF; Gouse H; Fuchs D; Carrico AW
J Neurovirol; 2020 Oct; 26(5):779-784. PubMed ID: 32728896
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
